Yup … and the B I G news will be the funding announcement
Trial commencement is subject to the filing by Race of an IND (Investigational New Drug application) with the FDA. “We remain on track to see the IND filed by the end of March,” said Mr Molloy. “It will be an important milestone for the Company.” Commencement of the trial is also subject to funding. Through an agreement with Biosynergy Partners, Race has been engaged in discussions with potential partners about funding of the trial.
Yup … and the B I G news will be the funding announcement Trial...
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.030(2.11%) |
Mkt cap ! $282.0M | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.45 | $1.40 | $163.8K | 115.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 31396 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |
